- Home
- BNTC vs OLMA Comparison
BNTC vs OLMA Comparison
Compare BNTC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- OLMA
- Stock Information
- Founded
- BNTC 1995
- OLMA 2006
- Country
- BNTC United States
- OLMA United States
- Employees
- BNTC N/A
- OLMA N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- BNTC Health Care
- OLMA Health Care
- Exchange
- BNTC Nasdaq
- OLMA Nasdaq
- Market Cap
- BNTC 352.5M
- OLMA 289.0M
- IPO Year
- BNTC N/A
- OLMA 2020
- Fundamental
- Price
- BNTC $13.63
- OLMA $4.60
- Analyst Decision
- BNTC Strong Buy
- OLMA Strong Buy
- Analyst Count
- BNTC 7
- OLMA 3
- Target Price
- BNTC $24.71
- OLMA $27.67
- AVG Volume (30 Days)
- BNTC 34.2K
- OLMA 848.8K
- Earning Date
- BNTC 05-16-2025
- OLMA 05-16-2025
- Dividend Yield
- BNTC N/A
- OLMA N/A
- EPS Growth
- BNTC N/A
- OLMA N/A
- EPS
- BNTC N/A
- OLMA N/A
- Revenue
- BNTC N/A
- OLMA N/A
- Revenue This Year
- BNTC N/A
- OLMA N/A
- Revenue Next Year
- BNTC N/A
- OLMA N/A
- P/E Ratio
- BNTC N/A
- OLMA N/A
- Revenue Growth
- BNTC N/A
- OLMA N/A
- 52 Week Low
- BNTC $5.74
- OLMA $2.86
- 52 Week High
- BNTC $16.90
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- BNTC 49.98
- OLMA 49.07
- Support Level
- BNTC $13.35
- OLMA $4.35
- Resistance Level
- BNTC $15.69
- OLMA $5.74
- Average True Range (ATR)
- BNTC 0.74
- OLMA 0.39
- MACD
- BNTC -0.03
- OLMA -0.05
- Stochastic Oscillator
- BNTC 20.46
- OLMA 17.99
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.